Renovorx
RenovoRx is a life sciences company dedicated to developing innovative targeted oncology therapies, focusing on addressing high unmet medical needs in cancer treatment. Their flagship product, RenovoCath, is an FDA-cleared drug-delivery device designed to enhance the intra-arterial administration of chemotherapy, specifically targeting locally advanced pancreatic cancer.
The company's proprietary Trans-Arterial Micro-Perfusion (TAMP) therapy platform aims to improve the effectiveness and safety of cancer therapies by delivering treatment directly to tumor sites while minimizing systemic side effects. Currently, RenovoRx is conducting a Phase III clinical trial, TIGeR-PaC, to evaluate the efficacy of its combination oncology product candidate against standard intravenous chemotherapy options.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.